Umnuaychoke Thongsa-ad, PhD
Lecturer
E-mail: umnuaychoke.tho@mahidol.ac.th
Tel: +66 02 201 5573
Education
Work Experience
Publication
Publication
- Establishment of a human induced pluripotent stem cell line MUi036-A from healthy male CD34+hematopoietic stem/progenitor cells
Stem Cell Research / August 2026
- Corrigendum to “ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling” (Biomedicine & Pharmacotherapy, (2025), 193, C, (118884), (S0753332225010789), 10.1016/j.biopha.2025.118884)
Biomedicine and Pharmacotherapy / March 2026
- Erratum to “ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling”(Biomedicine & Pharmacotherapy, (2025), 193, C, (118884), (S0753332225010789), 10.1016/j.biopha.2025.118884)
Biomedicine and Pharmacotherapy / February 2026
- ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling
Biomedicine and Pharmacotherapy / December 2025
- Improving hematopoietic differentiation from human induced pluripotent stem cells by the modulation of Hippo signaling with a diarylheptanoid derivative
Stem Cell Research and Therapy / December 2024
- Ex vivo expansion and functional activity preservation of adult hematopoietic stem cells by a diarylheptanoid from Curcuma comosa
Biomedicine and Pharmacotherapy / November 2021
Patents
• International application (PCT/TH2024/050046) – DIARYLHEPTANOID-BASED COMPOUNDS FOR EX VIVO EXPANSION OF HEMATOPOIETIC STEM CELL POPULATIONS AND A METHOD THEREOF
